Clinics I work with
My reviews
Selected research
-
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study.
Future oncology (London, England)
-
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.
Nature
-
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Contact me
- Request appointment
- Refer a patient
- (415) 885-3882
4.8